Richard L. Lindstrom MD - 12 May 2022 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Richard L. Lindstrom, M.D.
Issuer symbol
OCUL
Transactions as of
12 May 2022
Net transactions value
+$11,552
Form type
4
Filing time
16 May 2022, 16:13:12 UTC
Previous filing
27 Sep 2021
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Options Exercise $11,552 +9,469 +11% $1.22 99,469 12 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Options Exercise $0 -9,469 -100% $0.000000* 0 12 May 2022 Common Stock 9,469 $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, representing a right to purchase a total of 9,469 shares, became exercisable over four years, with 25% of the shares underlying the option vesting on November 1, 2013 and 2.0833% vesting monthly thereafter.